<i>N</i>-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation

Cannabinoid type 1 (hCB1) and type 2 (hCB2) receptors are pleiotropic and crucial targets whose signaling contributes to physiological homeostasis and its restoration after injury. Being predominantly expressed in peripheral tissues, hCB2R represents a safer therapeutic target than hCB1R, which is h...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2022-11-01
Seri Bilgileri:	Molecules
Konular:	cannabinoid receptors hCB2R selective ligands drug design in silico simulations mechanism of receptor activation
Online Erişim:	https://www.mdpi.com/1420-3049/27/23/8152
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!